A Practical Guide to Understanding and Treating Peripheral Artery Disease
- 1 June 2024
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 83 (6) , 565-579
Abstract
Peripheral arterial disease (PAD) is the third leading cause of atherosclerotic morbidity after coronary heart disease and stroke yet is widely underdiagnosed and undertreated. Treatment of risk factors such as diabetes and cigarette smoking can benefit patients with PAD. Patients should have adequate blood pressure and lipid control to decrease clinical manifestations and symptoms of PAD. Use of antithrombotic medications should be individualized to the patient depending on the presence of symptoms, revascularization, and comorbidities. All patient care providers, including physicians, pharmacists, nurse practitioners, and physician assistants, should incorporate PAD screening in their at-risk patients to improve access for appropriate earlier diagnosis, initiation of guideline directed therapy, and risk factor modification to reduce both major adverse CV and limb outcomes. The purpose of this narrative review is to provide an overview of PAD and summarize clinical trial evidence and guideline recommendations for screening and treatment to increase awareness among health care providers to ultimately have a positive impact on patient care.Keywords
This publication has 77 references indexed in Scilit:
- Home-Based Walking Exercise and Supervised Treadmill Exercise in Patients With Peripheral Artery DiseaseJAMA Network Open, 2023
- Antithrombotic Therapy for Symptomatic Peripheral Arterial Disease: A Systematic Review and Network Meta-AnalysisDrugs, 2022
- CYP2C19 genotype-guided antithrombotic treatment versus conventional clopidogrel therapy in peripheral arterial disease: study design of a randomized controlled trial (GENPAD)American Heart Journal, 2022
- Effect of a Home-Based, Walking Exercise Behavior Change Intervention vs Usual Care on Walking in Adults With Peripheral Artery DiseaseJAMA, 2022
- Smoking Cessation Improves Outcomes in Patients With Peripheral Artery DiseaseJAMA Cardiology, 2022
- Peripheral Artery Disease: Past, Present, and FutureThe American Journal of Medicine, 2019
- Clinical Efficacy and Safety of Cilostazol: A Critical Review of the LiteratureDrugs, 2015
- Characteristics and Long-Term Follow-Up of Participants with Peripheral Arterial Disease During ALLHATJournal of General Internal Medicine, 2014
- Management of peripheral arterial interventions with mono or dual antiplatelet therapy—the MIRROR study: a randomised and double-blinded clinical trialEuropean Radiology, 2012
- Quality Improvement Guidelines for Percutaneous Catheter-Directed Intra-Arterial Thrombolysis and Mechanical Thrombectomy for Acute Lower-Limb IschemiaCardioVascular and Interventional Radiology, 2011